Trial Profile

A Phase II, Randomized, Open-label, Controlled, Multicenter Study to Evaluate the Efficacy and Safety of M701 Combined With Systemic Therapy in Patients With Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 05 Aug 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs M 701 (Primary)
Indications Colorectal cancer; Fallopian tube cancer; Gastric cancer; Malignant ascites; Ovarian cancer; Peritoneal cancer
Focus Therapeutic Use
Sponsors YZY Biopharma

20 Jul 2025 Status changed from active, no longer recruiting to completed.
04 Jun 2024 Interim results (As of December 15, 2023, n=84 ) presented at the 60th Annual Meeting of the American Society of Clinical Oncology.
26 Feb 2024 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com